Shingles is a viral infection caused by the varicella-zoster virus—the same virus that causes chickenpox. If you've had chickenpox at any point in your life, the virus remains dormant in nerve tissue near your spinal cord. Years or even decades later, that virus can reactivate as shingles, causing a painful rash that typically appears as a band or stripe on one side of your body.
Learn About Paying Your FGUA Bill Online →
The Centers for Disease Control and Prevention reports that about 1 in 3 Americans will experience shingles in their lifetime. The infection most commonly affects people over age 50, though it can occur at younger ages, especially in people with weakened immune systems. The pain associated with shingles—called postherpetic neuralgia when it persists after the rash clears—can last for months or even years, significantly affecting quality of life.
What makes shingles particularly challenging is that you cannot catch it from someone else if you've already had chickenpox or received the chickenpox vaccine. However, a person with shingles can spread the varicella-zoster virus to anyone who has never had chickenpox or the vaccine, causing them to develop chickenpox rather than shingles. This is one reason why preventing shingles in vaccinated individuals protects vulnerable people in your community.
Understanding the basic facts about shingles helps you make informed decisions about prevention. The virus lies dormant in nearly everyone who had chickenpox before vaccines were widely available. Stress, certain medications, aging, and conditions that weaken immunity can trigger reactivation. Learning about prevention options gives you concrete ways to reduce your risk of this painful condition.
Takeaway: Shingles affects roughly one-third of Americans at some point. It's caused by the reactivation of the chickenpox virus and can cause long-lasting pain. Prevention through vaccination is a straightforward way to reduce your risk.
Shingrix is a two-dose vaccine that protects against shingles and related complications. The FDA approved it in 2017, and it has become the primary shingles prevention tool recommended by health authorities. Unlike older shingles vaccines, Shingrix is a recombinant vaccine, meaning it's made from a single component of the virus rather than a weakened form of the whole virus. This approach makes it highly effective without containing live virus.
Free Guide to Pay by Plate Illinois Billing →
The vaccine works by training your immune system to recognize and fight the varicella-zoster virus. When your body encounters the virus later, your immune system can mount a strong response, preventing shingles from developing or significantly reducing the severity of infection if it does occur. Clinical trials showed that Shingrix is more than 90 percent effective at preventing shingles in people over age 50, and this protection remains strong even 7 years after vaccination.
The two doses of Shingrix are given as injections in the arm, typically spaced 2 to 6 months apart. Most people receive the second dose within this timeframe, though the CDC notes that if circumstances prevent the second dose from being given within 6 months, it can still be given at any point afterward. You do not need to restart the series if there's a longer gap between doses. Common side effects are mild to moderate and include arm soreness, muscle aches, fatigue, or headache lasting a day or two. Serious side effects are rare.
One important detail: you do not need to have a history of shingles to receive Shingrix. The vaccine is recommended for all adults age 50 and older, regardless of whether they remember having chickenpox or not. People younger than 50 with certain risk factors—such as weakened immunity—may also benefit from the vaccine, a conversation worth having with a healthcare provider.
Takeaway: Shingrix is a two-dose, highly effective vaccine that protects over 90 percent of recipients. It's recommended for all adults 50 and older and can be given at any time, with doses spaced 2 to 6 months apart.
For many years, Zostavax was the only shingles vaccine available in the United States. Approved in 2006, it was a live attenuated vaccine—meaning it contained a weakened but still-live form of the virus. Zostavax offered meaningful protection, reducing shingles risk by about 50 percent in people over 60. However, it had notable limitations that led to the recommendation shift toward Shingrix.
Free Guide to Mold Removal Methods for Walls →
Zostavax could not be given to people with weakened immune systems because it contained live virus. It also required special storage conditions and had to be mixed before use, making it more complicated to administer. Most significantly, the protection from Zostavax declined over time. Studies showed that its effectiveness dropped from 50 percent initially to about 35 percent after 8 years. This meant that people vaccinated with Zostavax still faced substantial risk of shingles as time passed.
By contrast, Shingrix uses a non-live, recombinant technology and provides stronger, more durable protection. It can be given to immunocompromised individuals (though timing may need adjustment based on specific conditions). The vaccine can be stored in a standard refrigerator, making it easier for healthcare providers to manage. Most importantly, its protection remains robust over time, maintaining over 90 percent effectiveness even 7 years after vaccination.
In 2017, the CDC recommended Shingrix as the preferred vaccine for shingles prevention. People who previously received Zostavax can receive Shingrix. The CDC recommends waiting at least 12 months after Zostavax before getting Shingrix, though this timing can be discussed with your healthcare provider based on your specific situation. If you received Zostavax years ago and are now in your 50s or older, discussing Shingrix vaccination is a reasonable step.
Takeaway: Shingrix replaced Zostavax because it's more effective, lasts longer, works for more people (including those with weakened immune systems), and is easier to store. If you received Zostavax previously, you can still get Shingrix.
The CDC recommends Shingrix for all adults age 50 and older, whether or not they remember having chickenpox as a child. If you fall into this age group, Shingrix vaccination is considered a standard preventive health measure. The vaccine is particularly important if you experienced chickenpox as a child—which most people over 40 did before the chickenpox vaccine became standard—because your risk of shingles increases with age.
How to Delete Your Fitbit Account Guide →
Certain groups have especially strong reasons to discuss Shingrix with their healthcare provider. People with chronic medical conditions like diabetes or heart disease face higher shingles risk and should prioritize vaccination. Those with weakened immune systems—including people living with HIV, those taking immunosuppressive medications for conditions like rheumatoid arthritis, or individuals who have undergone organ transplantation—can receive Shingrix, though the timing relative to their specific condition requires coordination with their healthcare team. People undergoing cancer treatment should discuss vaccination timing with their oncologist.
Adults ages 19 and older with weakened immune systems—even if they're younger than 50—are recommended to receive Shingrix. This includes people with conditions that reduce immune function or those taking medications that suppress immunity. The reasoning is straightforward: a weaker immune system means higher risk of shingles, so prevention becomes more valuable. If you take medications for chronic conditions, asking your doctor whether your immune function might be affected is a practical step.
The timing of vaccination can be flexible. You don't need to get Shingrix at a specific moment; it's something you can do at a routine healthcare visit. However, there are situations where timing matters. If you're scheduled for cancer treatment or another procedure that will affect your immune system, getting vaccinated beforehand is preferable. If you take certain immunosuppressive medications, your healthcare provider may recommend waiting until you're in a more stable phase of treatment. The key is starting a conversation with your healthcare provider about whether and when Shingrix makes sense for you.
Takeaway: All adults 50 and older should consider
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.